Johnson & Johnson (JNJ) Tops Q4 EPS by 2c; Guides FY13 EPS Below Views
Tweet
Share
E-mailGet Alerts JNJ Hot Sheet
Price: $260.86 --0%
Financial Fact:
CASH DIVIDENDS PER SHARE: 0.8
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
CASH DIVIDENDS PER SHARE: 0.8
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $1.19, $0.02 better than the analyst estimate of $1.17. Revenue for the quarter came in at $17.6 billion versus the consensus estimate of $17.67 billion.
Johnson & Johnson sees FY2013 EPS of $5.35-.5.45, versus the consensus of $5.49.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Johnson & Johnson sees FY2013 EPS of $5.35-.5.45, versus the consensus of $5.49.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
- Rekor Systems, Inc. (REKR) Tops Q2 EPS by 3c
- Bragg Gaming Group Inc. (BRAG) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
